The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 10, 2018

Filed:

Apr. 28, 2011
Applicants:

Irfan Z. Ali, Woodbury, MN (US);

Donald L. Villalta, Minneapolis, MN (US);

Scott A. Sarkinen, Greenfield, MN (US);

Inventors:

Irfan Z. Ali, Woodbury, MN (US);

Donald L. Villalta, Minneapolis, MN (US);

Scott A. Sarkinen, Greenfield, MN (US);

Assignee:

Medtronic, Inc., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/168 (2006.01); G06F 19/00 (2018.01); A61M 5/142 (2006.01);
U.S. Cl.
CPC ...
G06F 19/3468 (2013.01); A61M 5/14276 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/50 (2013.01);
Abstract

A total dose of a therapeutic agent to be delivered to a patient by an infusion device over a total period of time is automatically divided into a plurality of unit doses to be delivered to the patient over a plurality of unit periods of time. The infusion device is automatically programmed to deliver one of the unit doses of the therapeutic agent to the patient over its respective unit period of time, after which the one unit dose is delivered, and a determination is made of whether an error occurred in delivering the one unit dose to the patient. Delivery of the total dose of the therapeutic agent to the patient may include iteratively automatically programming the infusion device to deliver successive unit doses upon determining that no error occurred in delivering a previous unit dose to the patient. Accordingly, the risk of improperly dosing the patient with the therapeutic agent in an event of a software or hardware anomaly within the infusion device is prevented or reduced.


Find Patent Forward Citations

Loading…